Inovio Pharmaceuticals, Inc. (Nasdaq: INO) announced strategic leadership appointments to support the advancement of its portfolio of DNA-based cancer immunotherapies ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE